We were delighted to receive our first sponsorship for the conference in April. Our thanks to Lorna and Terry McDevitt and all those at McDevitt Engineering for their support. I am sure this will be first of many and will make this conference a great success with the potential to be an annual event. Any excess funds will go towards next year’s conference.
Access information for the Western Infirmary Lecture Theatre is provided in the following documents:
Accessibility map: University Avenue - Western Infirmary
Joe Wouk asked us to post a 10 minute video of his address to the 4th Annual LDN Conference at UCSC in October, 2008. View his LDN Video here.
Joe talks about how he found Low Dose Naltrexone (LDN) and it’s impact on his MS condition.
Prof Jill Smith has announced the start of a new study into the use of LDN in children with Crohn’s disease. The success of the pilot study in Crohn’s where 60% of patients went into remission and 80% reported improved symptoms has inspired the team at Penn State University to apply successfully for funding for full studies in this disease. The trial is now recruiting patients and will be completed by July 2010. It is hoped that Prof Smith will be persuaded to present some preliminary data at the second European LDN conference in Glasgow in 2010.
The proposed trial into the use of LDN in Multiple Sclerosis is making progress. We have passed the second round of peer comment from outside experts and have now been invited to submit a full application to the Chief Scientists Office. This is a very positive step and indicates that the trial is viewed as being viable. We have several other hurdles to cross including gaining approval from the MHRA and ethics but things are well on there way and hopefully we will have secured funding by the time the conference takes place in April.
We have added a video from Joseph Wouk, one of the speakers at the First European LDN Conference.
This half hour video describes how LDN halted the progression of his Progressive Relapsing Multiple Sclerosis. It also explains how LDN works and the reasons why after 20 years of saving lives it is still unknown.
Joseph has written a book called Google LDN!, his attempt at Dana Paramita, the Buddhist version of Christian “good works”. You’ll laugh and cry through the first part of the book and be inspired by the second part. A man who refuses to give up in the face of insurmountable odds ends up completely healed despite the hopelessness that western medicine tells him he faces.
The first European LDN conference agenda has been released. Please visit the About page for details, via this link or from the top menu bar.
First European LDN Conference Agenda
We have added a selection of new LDN videos in the LDN Video section.
These are mostly from YouTube, and after watching, you can click on any video and go to YouTube for a further selection.
Please feel free to add your comments on any video by clicking the comments link at the top of each post.
I am delighted to report that the Chief Scientists Office in Scotland have requested that we apply now for full funding of our MS trial. This has taken almost one year to get to this stage as the process is slow and involves two sets of opinions from six external experts but we are getting there. This is virtually the green light for the trial and we will get the application processed as soon as possible. I am hopeful that we will begin the study before the conference in April and be able to report the findings in our second conference next year.
We are delighted to advise that another speaker for the conference has been confirmed. His name is Joseph Wouk, son of the famous author Herman Wouk ( Caine Mutiny etc) who is also an author and a man on a mission. He suffers from MS and has had a very good response to LDN so much so that he has written a book about his experience called ” Google LDN”. This should be available in the UK by the time of the conference and for those interested in a preview, there is a half hour blog on www.googleldn.com. Joseph spoke at the 4th LDN conference where I was lucky enough to meet him and invite him to the UK. We look forward enormously to his input.
